Abstract 4109: A 5-gene signature (sig) predicts clinical benefit from erlotinib in non-small cell lung cancer (NSCLC) patients (pts) harboring wild-type (wt) EGFR & KRAS
Year: 2011
Type: conference-abstract
Source: Cancer Research
Authors: Pierre Saintigny, Lixia Diao, Jing Wang, Luc Girard, Steven H. Lin, Kevin R. Coombes, Suyu Liu, J. Jack Lee, John N. Weinstein, Yang Xie, You H. Fan, Xi Ming Tang, Edward S. Kim, Roy S. Herbst, Anne Tsao, George R. Blumenschein, Li Mao, Scott M. Lippman, John D. Minna, Waun Ki Hong, Ignacio I. Wistuba, John V. Heymach
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2332913395
